Copyright © Inderes 2011 - present. All rights reserved.

Genetic Analysis

0.63 NOK

+4.17 %

Less than 1K followers

GEAN

Spotlight Stock Market

Medical Equipment & Services

Health Care

+4.17 %
-8.76 %
-10.71 %
-10.71 %
-30.17 %
-5.30 %
-66.03 %
-
-94.16 %

Genetic Analysis operates in the medical technology sector. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the IVD products are used, for example, for testing and analysis of bacteria and viruses. The largest operations are found in the Nordic market and the products are mainly resold to laboratories. The company is headquartered in Oslo, Norway.

Read more
Market cap
43.18M NOK
Turnover
8.51K NOK
Revenue
16.71M
EBIT %
-67.4 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20.5
2026

General meeting '26

28.5
2026

Interim report Q1'26

28.8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.